Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengnan Liu

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Acta Biochimica Et Biophysica Sinica|September 29, 2021
A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancerGuang Wu, Lan Li, Yuxin Qiu, et al.
Journal of Nanobiotechnology|May 19, 2024
Probiotic-derived amphiphilic exopolysaccharide self-assembling adjuvant delivery platform for enhancing immune responsesShouxin Sheng, Haochi Zhang, Xinyu Li, et al.
Protein & Cell|February 19, 2021
Potentiating CD8<sup>+</sup> T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signalingJuanjuan Yuan, Ting Cai, Xiaojun Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 24, 2025
Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD-1 Blockade in MSS Colorectal CancerQi-Long Wang, Zijie Chen, Xiaofei Lu, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Acta Biochimica Et Biophysica Sinica|September 29, 2021
A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancerGuang Wu, Lan Li, Yuxin Qiu, et al.
Journal of Nanobiotechnology|May 19, 2024
Probiotic-derived amphiphilic exopolysaccharide self-assembling adjuvant delivery platform for enhancing immune responsesShouxin Sheng, Haochi Zhang, Xinyu Li, et al.
Protein & Cell|February 19, 2021
Potentiating CD8<sup>+</sup> T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signalingJuanjuan Yuan, Ting Cai, Xiaojun Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 24, 2025
Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD-1 Blockade in MSS Colorectal CancerQi-Long Wang, Zijie Chen, Xiaofei Lu, et al.
Pageof 12